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Human ITCH E3 Ubiquitin Ligase Deficiency
Causes Syndromic Multisystem Autoimmune Disease
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Ubiquitin ligases play an important role in the regulation of the immune system. Absence of Itch E3 ubiquitin ligase in mice has been
shown to cause severe autoimmune disease. Using autozygosity mapping in a large Amish kindred, we identiﬁed a linkage region on
chromosome 20 and selected candidate genes for screening. We describe, in ten patients, identiﬁcation of a mutation resulting in trun-
cation of ITCH. These patients represent the ﬁrst reported human phenotype associated with ITCH deﬁciency. These patients not only
have multisystem autoimmune disease but also display morphologic and developmental abnormalities. This disorder underscores the
importance of ITCH ubiquitin ligase in many cellular processes.We describe ten Old Order Amish children with organome-
galy, failure to thrive, developmental delay, dysmorphic
features, and autoimmune inﬂammatory cell inﬁltration
of the lungs, liver, and gut. Extensive testing failed to
reveal a diagnosis. We used single-nucleotide polymor-
phism (SNP) autozygosity mapping to localize the disease
gene to chromosome 20q11 and subsequently found that
all affected patients were homozygous for a truncating
mutation in ITCH (MIM 606409), which codes for an E3
ubiquitin ligase. To our knowledge, we provide the ﬁrst
direct evidence connecting ITCH deﬁciency to human
disease.
The primary function of ubiquitin is to target proteins
for degradation in the protesome. Ubiquitination of target
proteins is important for immune regulation.1–3 Ubiquitin
tagging affects antigen processing by antigen-presenting
cells and promotes immunological tolerance by changing
signaling components to shift the balance away from acti-
vation and toward anergy.4–6 In mice, mutations of the E3
ligase Itch cause fatal autoimmune disease characterized by
histiocyte and lymphocyte inﬁltration of lungs, liver,
kidneys, and heart.7,8 Our ﬁndings have broad implica-
tions for the study of autoimmunity in humans and under-
score the important role of ubiquitination in the develop-
ment of other organ systems.
Three related Amish children were evaluated for poor
growth, developmental delay, hepatosplenomegaly, diar-
rhea, and chronic lung disease. Seven additional relatives
(Indiana¼5, Pennsylvania¼1,NewYork¼1)with a similar
phenotype were identiﬁed during a ﬁeld study and by
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strated multiple lines of common ancestry, and each was
the product of a consanguineous marriage (Figure 1).
Characteristic clinical features were dysmorphic facies,
failure to thrive, hepatomegaly, splenomegaly, multi-
system autoimmune disease, and delayed motor develop-
ment (Table 1). The patients ranged from 5 months to 23
years of age; the mean age was 4.2 years, and the median
age was 2 years. Growth was stunted, and patients dis-
played relative macrocephaly (typically at the 90th percen-
tile or above), weight and height below the 3rd percentile
(z-score less than 2), and body mass index below normal
(z-score less than 1). Six of ten patients required gastro-
stomy tube placement within the ﬁrst year of life after
having failed to gain weight with oral feedings, although
only two had overt symptoms of malabsorption. Distinc-
tive craniofacial features included frontal bossing, dolicho-
cephaly, orbital proptosis, ﬂattened mid-face with a promi-
nent occiput, small chin, and low, posteriorly rotated ears
(Figure 2). The liver was typically 4–8 cm below the costal
margin, and the spleen was 4–6 cm below the costal
margin. The remainder of the physical examination was
signiﬁcant for global hypotonia and campto- or clinodac-
tyly. All children were delayed in gross motor skills (they
often did not walk until 3–4 years of age) and cognitive
skills (they usually required special help in school). Several
of the children were treated for recurrent infections.
Complete blood counts, when available, did not demon-
strate abnormal white blood cell counts, hematocrits,
platelet counts, absolute neutrophil counts, or absolute
lymphocyte counts except during acute infections.
Three patients had autoimmunehepatitis resulting in ala-
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Figure 1. Pedigree Demonstrating Autosomal-Recessive Inheritance of Traits from Several Common Ancestors
Information obtained from a community genealogy book.22 Unaffected siblings (both carriers and noncarriers) are not displayed because
of space constraints. Of the individuals tested, carriers include the parents of VII-1, the father of VII-3 (no record of testing the mother),
the mother and three siblings of VII-4 and VII-5 (no record of testing the father), two brothers of VII-7 and VII-8, and one sister of VI-2.(AST) levels that were 3–30 times the upper limit of normal.
One had isolated anti-liver/kidneymicrosomal (LKM) anti-
bodies, one had both LKM and antinuclear antibodies
(ANA), and a third had anti-neutrophil cytoplasmic anti-
bodies (pANCA). Liver biopsies on two children showedTable 1. Clinical and Autoimmune Features Seen in ITCH-Deficient Pa
Clinical Features
Patient Number
VII-4 VII-5 VI-2 VII-3
Hepatomegaly and/or splenomegaly þ þ þ þ
Failure to thrive þ þ þ þ
Developmental delay þ þ þ þ
Dysmorphic features þ þ þ þ
Relative macrocephaly þ þ þ þ
Chronic lung disease þ þ - þ
Hypotonia þ þ þ þ
Autoimmune disease þ - þ -
–Hypothyroidism þ - þ -
–Hepatitis - - - -
–Enteropathy þ - - -
–Diabetes mellitus - - - -
Current age or age at death
(in years)
12 2 3 3
Currently living? (yes or no) Y Y Y N
448 The American Journal of Human Genetics 86, 447–453, March 1dense periportal mixed inﬂammatory inﬁltrate with inter-
face activity consistentwith autoimmunehepatitis (Figures
3A and 3B). In one of these children, there was substantial
bridging ﬁbrosis associated with profound loss of hepato-
cytes. One child had improvement in transaminases intients
Percent
AffectedVII-6 VII-8 VII-1 VI-1 VII-2 VII-7
þ - þ þ þ þ 90%
þ þ þ þ þ þ 100%
þ þ þ þ þ þ 100%
þ þ þ þ þ þ 100%
þ þ þ þ - þ 90%
þ þ þ þ þ þ 90%
- - þ ? þ ? 60%
þ - þ þ þ - 60%
- - þ - þ - 40%
þ - þ - þ - 30%
- - þ - - - 20%
- - - þ - - 10%
9 4 6 23 0.6 1.2
Y Y Y Y N N
2, 2010
Figure 2. The Two Index Patients
Photos were used with the family’s consent.
Figure 3. Histology Showing the Effects of ITCH Deficiency in
Multiple Tissues
(A) A mid-power view of the liver in a subject with autoimmune
hepatitis shows a dense mixed inﬂammatory inﬁltrate throughout
the periportal region and an accompanying cholangitis and reac-
tive proliferation of bile ducts.
(B) Mid-power view of the liver in another subject with autoim-
mune hepatitis shows a mixed inﬂammatory cell inﬁltrate in the
periportal region.
(C) Lung showing a patchy expansion of the interstitium by
lymphocytes and clusters of macrophages in the alveolar
airspaces. There is no ﬁbrosis.
(D) Higher magniﬁcation of the lung exhibiting a mild interstitial
lymphocytic inﬁltrate. The central alveolar airspace contains
a collection of macrophages (arrow).
(E) Although liver architecture is intact in a subject with normal
liver enzymes but hepatomegaly, some multinucleated hepato-
cytes are present, and periportal hepatocytes contain large Lafora-
body-like inclusions (arrow); there is no inﬂammation.
(F) An electron micrograph of the same specimen as in 3E reveals
heterogeneous cytoplasmic material (bounded by a dotted line):
small droplets of fat and endoplasmic reticulum displace mito-
chondria eccentrically (inset shows a normal hepatocyte for
comparison).16response to corticosteroids, one died of lung disease before
autoimmune hepatitis was treated, and a third is currently
under evaluation.
Two children had autoimmune enteropathy that re-
sulted in chronic diarrhea. One of these children had
anti-enterocyte antibodies, pANCA, and anti-smooth-
muscle antibodies (SMA), whereas another had anti-enter-
ocyte antibodies only. Both children had intestinal biop-
sies that showed lymphocytic inﬂammation of the lamina
propria; one had severe villous blunting (not shown). The
child with mild inﬂammation improved on low-dose
steroids, whereas the second improved after being treated
with an array of immunosuppressives, including cortico-
steroids, rapamycin, azathioprine, and tacrolimus.
Four of ten children developed hypothyroidism. Auto-
antibodies were found in the three children who were
tested: two tested positive for anti-thyroid peroxidase
(TPO), and one tested positive for anti-thyroglobulin.
Biochemical abnormalities resolved with appropriate
thyroid hormone replacement. One subject was diagnosed
with type 1 diabetes mellitus; autoantibodies were not
measured.
Nine of ten children had chronic lung disease, often
characterized as asthma. Five children had chronic lung
opacities seen on chest radiography (n ¼ 3) or chest
computed tomography (n ¼ 2). Three had a chronic
oxygen requirement, and one child required tracheostomy
placement and home ventilator support. Lung disease was
treated with bronchodilators, antibiotics, and occasionally,The Americorticosteroids with apparent response. A wedge lung
biopsy of one severely affected child revealedmononuclear
inﬁltrates expanding the interstitium and clusters of
macrophages ﬁlling the alveolar airspaces (Figures 3C
and 3D). These ﬁndings are somewhat difﬁcult to classify
but seem to ﬁt best as a cellular, nonspeciﬁc interstitial
pneumonitis. Three children died of respiratory failure.
Intermittent hepatomegaly was seen in several children
in the absence of elevated serum transaminases. A liver
biopsy in one such child was read as normal, but another
demonstrated large pink inclusions in the cytoplasm of
periportal hepatocytes after hematoxylin and eosin stain-
ing; electron microscopy of these cells, but not other
hepatocytes, revealed cytoplamic accumulations of large
amounts of smooth endoplasmic reticulum (Figures 3Ecan Journal of Human Genetics 86, 447–453, March 12, 2010 449
and 3F). A third child with intermittent marked elevations
in transaminases had steatohepatitis on one biopsy and
giant cell hepatitis without typical autoimmune features
on another.
Total genomic DNA from whole blood was isolated with
the PureGene DNA Isolation Kit (QIAGEN, Valencia, CA,
USA) according to the manufacturer’s protocol. SNP geno-
typing was performed with the GeneChip Mapping 10K
Assay Kit (Affymetrix, Santa Clara, CA, USA) as previously
described.9 In brief, 250 ng of double-stranded genomic
DNA was digested with XbaI, the restriction fragments
were ligated to adapters, and the ligated products were
ampliﬁed in quadruplicate with a generic primer. PCR
products were puriﬁed, fragmented with DNase, labeled
with terminal deoxynucleotidyl transferase, and ﬁnally
hybridized to a GeneChip Human Mapping 10K Array
(XbaI 142, 2.0). Microarrays were then washed with
a ﬂuidics station, incubated, and scanned with the Gene-
Chip Scanner 3000 enabled by GeneChip GCOS software
(Affymetrix).
Data analyses ascertained genomic regions identically
homozygous among affected individuals and assumed
mutation and locus homogeneity. We calculated cumula-
tive two-point LOD scores (location scores) for each shared
block of homozygous SNPs to determine the relative likeli-
hood that the shared homozygous region harbored the
disease gene. We used SNPs bounding a shared block to
construct a candidate gene list by using the NCBI Genome
Browser. For each gene, we assessed function and expres-
sion to generate a priority list for sequencing. Suitable
candidates were subjected to polymerase chain reaction
(PCR) ampliﬁcation and sequencing of the coding regions
and adjacent intron-exon boundaries. PCR primers were
designed with Primer3. A 25 ml reaction was prepared with
1 U of Taq polymerase (QIAGEN, Valencia, CA), 200 mM
each of dATP, dCTP, dGTP, and dTTP, 2.5 ml of 103 PCR
buffer (QIAGEN), and 50 ng of genomic DNA. We used
a Perkin-Elmer 480 or Applied Biosystems GeneAmp
9700 thermocycler to cycle the reaction for 30 cycles
(30 s at 96C, 10 s at 60C, 30 s at 72C), and this was fol-
lowed by an 8 min incubation at 72C. PCR products were
sequenced with the BigDye Terminator cycle sequencing
protocol (Applied Biosystems). Extension products were
then size-fractionated on an ABI 310 Genetic Analyzer.
Coding exons and adjacent intronic regions from candi-
date genes from patient sequences were compared to the
human reference sequence and dbSNP (NCBI) so that path-
ogenic variants could be detected.
Genome-wide autozygosity mapping for ﬁve patients
identiﬁed a large homozygous block in the pericentro-
meric region of chromosome 20 (Figure 4A). The 19 MB
region was bounded by SNPs rs2038383 and rs2067084
and contained 258 known or hypothetical genes. Five of
these candidate genes were sequenced on the basis of
their predicted function. Prominent autoimmune disease
in one patient directed candidate gene sequencing to
ITCH because of similar autoimmune ﬁndings in Itch/450 The American Journal of Human Genetics 86, 447–453, March 1mice. Sequence analysis of ITCH revealed a homozygous
single basepair insertion in exon 6 (c.394_395insA)
(Figure 4B). This frameshift mutation was predicted to
truncate ITCH at amino acid position 139 (Figures 4C
and 4D). All affected individuals were homozygous for
this variant, and among those tested, their parents were
heterozygous. None of the nine heterozygous siblings or
parents were symptomatic or dysmorphic. Among 12
unaffected siblings tested from ﬁve families, none were
homozygous for the mutation. We developed a SimpleP-
robe PCR assay for ITCH c.394_395insA to facilitate rapid
carrier and diagnostic testing. Genotyping of 80 random
Lancaster County Old Order Amish identiﬁed no carriers.
This is not unexpected because all affected individuals
descend from the Indiana Amish, a group genetically
distinct from the Lancaster County Amish. We did not
have banked DNA we could analyze from the Indiana
Amish.
Human ITCH deﬁciency results in a complex phenotype
that affects physical growth, craniofacial morphology,
muscle development, and immune function. The conse-
quences of ITCH deﬁciency in humans appear to be similar
to those in Itch/ mice. Nine of the ten affected children
had chronic lung disease, and respiratory failure caused
death in three. This lung disease, similar to that seen in
mice, was probably a result of immune dysregulation.
Pathology results revealed a nonspeciﬁc interstitial pneu-
monitis that has been linked previously to autoimmune
disease.10,11 Five other patients had autoimmune disease
in other organ systems.
ITCH attaches ubiquitin to substrate proteins.12 Ubiqui-
tination of the T cell receptor mediates its downregula-
tion,7 and downstream signaling events are altered by
ubiquitination of proteins such as JUNB, which may
inhibit IL-2 production and thus T cell proliferation.8
Dysfunction of E3 ligases, which catalyze the ﬁnal step of
ubiquitin attachment, can lead to indiscriminate T cell
activation and loss of tolerance to self-antigens.1,13 In
mice, mutations of the E3 ligase Itch cause fatal autoim-
mune disease characterized by histiocyte and lymphocyte
inﬁltration of the lungs, liver, kidneys, and heart.7,8
‘‘Itchy’’ mice have a skewed Th2 phenotype and dysfunc-
tional B cell responses.14 The mice are small, dysmorphic,
and pruritic and have elevated levels of circulating
lymphocytes, immunoglobulins, and anti-nuclear anti-
bodies. Both antigen processing and T cell anergy are
abnormal in affected animals,8,15 and multiple organs are
inﬁltrated with lymphocytes, particularly autoreactive B
cells, that lead to fatal lung disease early in life.7,8,14
Human ITCH deﬁciency causes disease beyond the
immune system, consistent with the role of protein
ubiquitination in cell trafﬁcking, functional activation,
proteosomal degradation, and programmed cell death.16
In humans, ITCH is strongly expressed in the GI tract,
pancreas, neuronal cells, and lymphoid tissue but is
present in many other tissues (Protein Atlas; see Web
Resources). The craniofacial abnormalities that lead to2, 2010
Figure 4. Genetic Mapping and Gene Mutation in ITCH-Deficient Patients
(A) Genetic mapping to chromosome 20p11.2-q12. A block of 37 contiguous SNPs on chromosome 20 provided overwhelming evidence
for identity-by-descent in ﬁve affected Old Order Amish patients.
(B) The ITCH sequencing trace; sequencing of the 23 coding exons of ITCH identiﬁed a single base-pair insertion in exon 6. Panel 1 shows
sequence from a control sample demonstrating normal exon 6 sequence. Panel 2 depicts sequence from an obligate heterozygote
showing the single base-pair insertion. Panel 3 illustrates homozygosity for the c.394_395insA mutation (the red A denotes the
mutation).
(C and D) The imputed effect of the insertion mutation on ITCH translation. The mutation causes a frameshift predicted to misincor-
porate eight amino acids in the peptide chain and cause a premature termination at codon 140. The truncated ITCH protein lacks the
three WW domains as well as the HECT domain that contains the E2 interaction (active) site.17the distinctive facies in all of these children suggest a devel-
opmental role for ITCH in nonhematopoietic cells. The
organomegaly and occasional cytoplasmic inclusions
suggest possible storage of nonubiquitinated protein in
the cells. Ubiquitin-related protein accumulation in the
brain has been associated with some CNS diseases17 and
may provide an explanation for psychomotor delays seen
in affected children. A recent report suggests that ITCH
might regulate NOD2 signaling, which could explain the
bowel inﬂammation in two of these patients.18The AmeriThe link between ITCH deﬁciency and immune dysregu-
lation has implications for treatment. Screening for auto-
immune disease is important in these children, and auto-
immune manifestations in liver, intestine, and lung
sometimes respond to immunosuppressive treatment. In
patients who can be diagnosed early in life, such therapy
could halt or slow progression of the disease. Moreover,
exciting oncology research in recent years has focused on
drugs that might affect ubiquitin pathways and thus allow
more speciﬁc molecular therapies for the disorder.19 Thecan Journal of Human Genetics 86, 447–453, March 12, 2010 451
severe phenotype in a few of the patients even raises
consideration of bone marrow transplantation as a poten-
tial therapy.20
The discovery of involvement of a ubiquitin ligase in
autoimmune disease has signiﬁcance beyond this isolated
Amish community. The disease demonstrates the vital
importance of ubiquitin pathways in the cell signaling
that controls T cell responsiveness in humans. The fact
that only some of the ITCH-deﬁcient patients had severe
autoimmune disease suggests that, not surprisingly, other
genetic modiﬁers or environmental factors contribute to
T cell anergy. On the other hand, it is notable that other
ubiquitin ligases in the cell fail to complement the defect
enough to restore a normal phenotype.
Further studies will be needed to clarify the pathophysi-
ology of ITCH deﬁciency. Morphologic examination of the
affected tissues might further clarify the site of substrate
accumulation or the speciﬁc subcellular site of toxicity.
Functional assays will be necessary for determining the
fate of ubiquitinated substrates such as JUN in the cell
and for studying downstream signaling pathways such as
those involving NOTCH. Detailed studies of immunolog-
ical function, T cell regulation, and autoimmunity are
underway.
Our report describes an approach to the elucidation of
a novel genetic disorder within an isolated population.
Prior to our investigations, several of these children had
undergone extensive medical evaluations. The cause of
their illness had not been found. The molecular diagnosis
that relates the disease process to a mutation in the
immune regulatory gene ITCH provides a new biological
framework within which clinical observations and selected
laboratory data can be used for studying the natural history
of this disorder and evaluating therapies. As in our
previous reports about genetic mapping in the Old Order
Amish and Mennonite populations,21 this approach repre-
sents a cost-efﬁcient way to discover the genetic basis of
disease.Supplemental Data
Supplemental Data include one table and can be found with this
article online at http://www.cell.com/AJHG.Acknowledgments
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